These are some of the main conclusions presented in a wide-ranging White Paper (policy document) released today by the European Medical Research Councils (EMRC) – the European Science Foundation’s membership organisation for all medical research councils in Europe.
The EMRC White Paper, ‘Present Status and Future Strategy for Medical Research in Europe’, will be launched at a meeting held in Brussels on 6 December 2007 co-chaired by Janez Potocnik, EU Commissioner for Science and Research, and Professor Liselotte Højgaard, Chair of the EMRC. The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe compared with its global competitors, together with an assessment of new challenges facing Europe’s citizens, including changing patterns of disease, environmental issues including global warming, and changing demographic factors such as an ageing population.
The White Paper makes several key recommendations aimed at strengthening and improving medical research in Europe. These include:
· Implementation of best practice for funding and performing medical research – with distribution of funding in competition based on excellence and evaluated by peer review
· Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies
· Revision of EC directives related to medical research
· Implementation of equal opportunities for all researchers
· A doubling of public funding of medical research in Europe within the next ten years – to a minimum of 0.25% of gross domestic product (GDP)
The EMRC White Paper recognises that the newer countries of the European Union require extra investment in research infrastructure to bring their facilities to the level of the older countries within the union.
Professor Højgaard said, “We believe that this White Paper presents a powerful case for the future strategy of medical research in Europe, which will benefit society in many ways and will improve the quality of life for the citizens of Europe and the rest of the world and meet the difficult challenges we are facing. A strong base in medical research will also lay the foundations for a more successful medical industry in Europe.”
Commissioner Janez Potocnik for Science and Research said, “What Europe needs is a more coherent, strategic approach to research at European level. This was the driving philosophy behind our Green Paper on the European Research Area, and one which the EMRC have taken up in their paper. That national medical research councils are teaming up to better organise medical research in Europe is a very significant signal. I look forward to exploring the EMRC’s ideas and help them deliver on their objectives”.
The Heads of Medical Research Councils in Europe, Editors-in-Chief of Medical Journals and the Presidents of Medical Learned Societies will be invited to debate the White Paper and propose actions to bring the EMRC strategy to fruition at a briefing conference on 30 January 2008 in Frankfurt.
Thomas Lau | alfa
Decision-making research in children: Rules of thumb are learned with time
19.10.2016 | Max-Planck-Institut für Bildungsforschung
Young people discover the "Learning Center"
20.09.2016 | Research Center Pharmaceutical Engineering GmbH
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering